Sandra Ro

Executive Director, Head of Product Development & Research, FX, IR & Equiti
CME Group

Sandra Ro is Executive Director, Global Head of Foreign Exchange (FX) Research and Product Development of CME Group. She is responsible for the development of FX solutions within listed and cleared OTC products, as well as CME Europe, a new exchange based in London, launched in April 2014.

Ro brings her client advisory, structuring and trade execution experience in OTC FX forwards and options to CME Group. Prior to joining CME Group in 2011, Ro led the EMEA FX and interest rates mergers & acquisitions advisory group in connection with hedging derivatives in large cross border transactions, as well as in IPOs, bond issuances, and special situations.

Before that, Ro worked at Deutsche Bank as a FX structurer on the London trading floor, providing hedging solutions for corporates as well as REITS and private equity clients.

Ro holds a M.B.A. in Finance from London Business School and a double B.A. Degree in History and Studies in the Environment from Yale University with a concentration in the Proliferation of Chemical and Biological Weaponry in the 20th century.

Check out the incredible speaker line-up to see who will be joining Sandra.

Download The Latest Agenda

TRADING FX IN A NEW REGULATED MARKET

Thursday, April 9th, 2015

09:40 INDUSTRY KEYNOTE: The big issue - How is the FX industry reacting to “a new derivative order” post EMIR and Dodd-Frank implementation?

• Exploring the impact regulation will have on the operating activities of the various parties in the industry

• Comparing EMIR with the Dodd-Frank Act – clarifying the opportunities these regulations aim to bring

• Have the timelines been realistic to achieve the goals set to the industry?

• Have counterparts had enough education to be able to successfully operate in the new environment?